Swedbank AB Buys New Shares in HealthEquity, Inc. $HQY

Swedbank AB bought a new stake in HealthEquity, Inc. (NASDAQ:HQY) in the 4th quarter, HoldingsChannel reports. The institutional investor bought 437,300 shares of the company’s stock, valued at approximately $40,061,000.

Several other hedge funds have also recently added to or reduced their stakes in the business. Xponance Inc. raised its position in HealthEquity by 0.8% in the third quarter. Xponance Inc. now owns 12,265 shares of the company’s stock worth $1,162,000 after purchasing an additional 102 shares in the last quarter. Truist Financial Corp raised its position in HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after purchasing an additional 119 shares in the last quarter. Fiduciary Trust Co raised its position in HealthEquity by 3.4% in the third quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC raised its position in HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after purchasing an additional 123 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in HealthEquity by 9.5% in the fourth quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock worth $178,000 after purchasing an additional 168 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Ratings Changes

HQY has been the subject of several recent research reports. JPMorgan Chase & Co. dropped their price target on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research report on Wednesday, March 18th. UBS Group set a $110.00 price target on shares of HealthEquity in a research report on Tuesday, February 17th. Barrington Research reissued an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research report on Friday. BTIG Research dropped their price target on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. Finally, Royal Bank Of Canada dropped their price target on shares of HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a research report on Wednesday, March 18th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $111.79.

HealthEquity Stock Performance

NASDAQ HQY opened at $88.11 on Monday. The firm has a market cap of $7.39 billion, a price-to-earnings ratio of 35.82, a PEG ratio of 1.60 and a beta of 0.19. The company has a 50 day moving average of $82.48 and a 200-day moving average of $86.92. The company has a current ratio of 3.27, a quick ratio of 3.27 and a debt-to-equity ratio of 0.45. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.05. The company had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The business’s revenue was up 7.3% on a year-over-year basis. On average, equities analysts forecast that HealthEquity, Inc. will post 3.84 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.